TY  - JOUR
AU  - Álvarez-Palomo, Belén
AU  - Veiga, Anna
AU  - Raya, Angel
AU  - Codinach, Margarita
AU  - Torrents, Silvia
AU  - Ponce Verdugo, Laura
AU  - Rodriguez-Aierbe, Clara
AU  - Cuellar, Leopoldo
AU  - Alenda, Raquel
AU  - Arbona, Cristina
AU  - Hernández-Maraver, Dolores
AU  - Fusté, Cristina
AU  - Querol, Sergi
PY  - 2022
DO  - 10.1186/s13287-022-02961-6
UR  - http://hdl.handle.net/10668/20362
T2  - Stem cell research & therapy
AB  - The increasing number of clinical trials for induced pluripotent stem cell (iPSC)-derived cell therapy products makes the production on clinical grade iPSC more and more relevant and necessary. Cord blood banks are an ideal source of young, HLA-typed...
LA  - en
KW  - Cord blood
KW  - Cord blood banks
KW  - GMP manufacturing
KW  - HLA matching
KW  - Hematopoietic progenitor cells
KW  - Induced pluripotent stem cells
KW  - Antigens, CD34
KW  - Blood Banks
KW  - Fetal Blood
KW  - Homozygote
KW  - Induced Pluripotent Stem Cells
TI  - Public Cord Blood Banks as a source of starting material for clinical grade HLA-homozygous induced pluripotent stem cells.
TY  - research article
VL  - 13
ER  -